Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Over the past 30 days, the average Off Exchange & Dark Pool volume has been 60.28%.
Timberwolf, I've looked at as much short interest and dark pool short volume as is available. My guess of how much money the shorts are down, translates to a marketcap well past the $1 mark. And that's just for them to break even. IMHO this is not financial advice to anyone here, I've done over 100 hours of research.
REASONABLE MARKET CAP guesses??
Current market cap around $48 Mil... Goes to 50 cents and they have a market cap of $143 Million..
Be nice to see them talk about the potential 'revenue' stream off the licensing deal, give some insight into what they see happening.
Happy adding day ..
Not much,out of powder.
Accumulating Time! Breakout Any Moment! News will come of the Conference this week and or Something Else i predict.
Correct , thankyou
If you look at the month chart you can see possibly the most beautiful bull flag I've ever witnessed, with the bollinger bands tightly closing. I'm in love lol xD
The silence is everything ;)
Tell you go to abga, 50cent spread
super pumpers😉 great day trade
make jus très heureux !
Fighting back today...
Check BLIS by the way jus, great chart play.
That $ 75mil dilution must be in play today....watch for filing out....no way in .19 this morning and go .16 red now
Golden cross has occured at .17 , SMA 200 and SMA 50 have now crossed, this could get interesting :)
LEVEL 2 ACTIVITY DEAD ALL EYES GLUED TO WEBSITE FOR ABSTRACT TITLE MENTION OR ANYTHING RELATED TO NAPO
ITS COMING ONLY A MATTER OF TIME THE SHIT IS DUE TODAY
I REPEAT, NOT EVERYTHING HAS BEEN UPDATED AS OF YET
DONT PANIC
APRIL 24, 2024 at 10:00 AM ET
Abstract Titles, including LBAs, Posted on meetings.asco.org
NOT ALL THINGS HAVE BEEN UPDATED AS OF 9;28AM
Did Jaguar posted anything on ASCO website...
DONT PANIC
APRIL 24, 2024 at 10:00 AM ET
Abstract Titles, including LBAs, Posted on meetings.asco.org
APRIL 24, 2024 at 10:00 AM ET
Abstract Titles, including LBAs, Posted on meetings.asco.org
APRIL 24, 2024 at 10:00 AM ET
Abstract Titles, including LBAs, Posted on meetings.asco.org
0 SHARE AVAIL TO SHORT, 60% FEE ABSTRACT TITLES POSTED IN T MINUS 38 MINUTES... TIK TOK TIK TOK
DATES TO KNOW
APRIL 24, 2024 at 10:00 AM ET
Abstract Titles, including LBAs, Posted on meetings.asco.org
APRIL 24, 2024
Early Registration Deadline
MAY 13, 2024
Oral Abstract presentation slide deadline. Materials must be uploaded to ASCO's Speaker Center Website
MAY 20, 2024
Poster and Rapid Oral Abstract presentation presentation materials (slides and/or posters). Materials must be uploaded to ASCO's Speaker Center Website
MAY 23, 2024 at 5PM et
Majority of abstracts are released on asco.org/abstracts (Late-breaking Abstracts will be released at 7:00 AM CT on their day of presentation at the meeting)
MAY 31 - JUNE 4, 2024
ASCO Annual Meeting (Chicago, IL)
Damn I wish I had a buy order set when it zoomed down to .11s the other evening.
I kinda understand your point here. It's a situation of why? I don't have time to DD Jaguar thoroughly. I have been day trading for about 20 years. Option, future, penny stocks, SPY, QQQ, NVDA, META and believe it or not CMKX. for this one I'll hold (don't do it coz of I do). I held $ZOM and it paid off nicely. For Jaguar I'll roll the dice. GLTA. PEACE
P.S for entertaining purpose only, I'm betting that market will ends up READ on THURSDAY close. Have a good market.
If it breaks the 38.2% fib support lvl today, we could have some serious attention on JAGX in the market.
With Conference This Week! This could have Significant Gains by End of Week!
Extremely low volume however it broke the first support Fibonacci support lvl. Let's see if the German market responds
Really low volume today
Needless to say it merely cannot exceed $75 million with no timeframe…. Could be $20 mill or $50 mill who knows and the best thing its not just what your insinuation of all being comman shares.they mentioned other avenues such as preferred shares….
SITTING HERE LOOKING AT THE 5 DAY...1 AND 3 MONTH CHART ON JAGX AND I DONT THINK YOU CAN FIND ANY SWEETER!!...SHE GOT STRONGER ALL DAY TODAY...GOTTA REAL GOOD FEELING ABOUT TOMORROW......JAGX DUE A HUGE MONSTROUS BREAKOUT ANYTIME AND THE COMPANY SEEMS TO KNOW ITS COMING...GLTA JAGX PEEPS!!!!!!$$$$$$$
I'll be up at 4am tomorrow so if I catch wind of any news drop I'll post for everyone :D
Nice recovery from last evenings AHs drop to .11
People are missing key facts here, the Napo pharmas abstract gets either accepted tomorrow or not for the presentation at it's booth for the conference in June. They already have a booth#, this is their first time presenting, they will be presenting near ImmunityBio, and among top billion dollar companies. look it up on my previous posts. Accepted means good news, they are going either way they have a BOOTH#. Do you think company wants to present TOPLINE PH3 data in June with a stock price under $1? THINK!!!!!! 🧐🧐
Gap fill .26 then 50s then $1 this stock is going to fly
A company that is suffering might do that. That is not the case here. Shelf will be used for funding FDA timeline, shelf will not be used like your negativity suggests
well recognized the RETAIL sector is not likely to move a stocks share price on their own.. That for it to happen in earnest, the bigger players on Wall Street NEED to be involved.
Why tho they tabled the r/split, couple that with the pending PH 3 PR, couple that with the announcement of authorizing up to $75 Mil in share sales??
You have to assume the company knows they need to move the share price up to around $4-5 so that the street can start to ''participate'..
Still have to hope the retail sector can move this up to say 50 cents first. Cut down the darn size of the r/split..
You could literally throw yesterdays trading Action out the window that was a doozy. Wow I've never seen such a dump then escalate move like with today's action. Know what you own. I'm not selling all my shares on initial pump,holding half more than a year. After FDA approval this goes $25+, r/s will not be needed, the shelf offering yesterday will fund the rest of they way.
in the meantime this will pump and dump over a $1 after ph3 data, it might even go $5+ and stay there like ImmunityBio, which is another company presenting at the conference right next to us.
Play it smart boys.
Strong bullish sign
Oui
You and day traitor amis dump on good people, mess up stock
Go to abga, bon trading there
Yes I flip in and out...I saw after hour tank .12 scare hell me out. ....nice see recover but next move....I m not sure if pps can recover ...$75mil!
We have almost fully recovered from the flash crash yesterday. honestly that's incredible it only took one trading day to stay within the 3 month bollinger bands!! WOW
Oui oui
You say dat yesterday
maintenant allez-vous-en
Followers
|
134
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
6959
|
Created
|
12/01/15
|
Type
|
Free
|
Moderators SmellMyFinger |
Jaguar Health, Inc. $JAGX
Bringing Plant-based Medicines to Life™
Pharmaceutical Manufacturing
San Francisco, California
Jaguar Health’s organizational framework is designed to enable our product pipeline to reach the world’s interconnected marketplace, allowing for development and commercialization opportunities worldwide.
Products:
Mytesi Crofelemer 125mg delayed release tablets
Mytesi is FDA-approved for symptomatic relief of noninfectious diarrhea in adults with HIV/AIDS on antiretroviral therapy
Mytesi has a novel mechanism of action that modulates chloride secretion in the gastrointestinal tract, reducing excessive chloride and accompanying water flow and relieving watery diarrhea.
Mytesi is not indicated for the treatment of infectious diarrhea. In clinical studies, the most common adverse reactions occurring at a rate greater than placebo were upper respiratory tract infection (6%), bronchitis (4%), cough (4%), flatulence (3%), and increased bilirubin (3%).
Canalevia-CA1 Crofelemer delayed release tablets
Distributors listed:
https://www.canalevia.com/distributor-information
CANALEVIA-CA1 is conditionally approved for the treatment of chemotherapy-induced diarrhea (CID) in dogs.
Conditionally approved by FDA pending a full demonstration of effectiveness under application number 141-552.
CAUTION: Federal (USA) law restricts this drug to use by or on the order of a licensed veterinarian. It is a violation of Federal Law to use this product other than as directed in the labeling.
Pipeline: https://jaguar.health/pipeline/
About the Jaguar Health Family of Companies
Jaguar Health, Inc. (Jaguar) is a commercial stage pharmaceuticals company focused on developing novel proprietary prescription medicines sustainably derived from plants from rainforest areas for people and animals with gastrointestinal distress, specifically associated with overactive bowel, which includes symptoms such as chronic debilitating diarrhea, urgency, and bowel incontinence.
Jaguar Health https://jaguar.health/
Napo Pharmaceuticals https://napopharma.com/
Napo Therapeutics https://napotherapeutics.com/en/
https://www.magdalenabiosciences.com/
Magdalena is a joint venture formed by Jaguar Health and Filament Health. The company holds an exclusive license to Jaguar's proprietary library of approximately 2,300 highly characterized medicinal plants and 3,500 plant extracts for designated therapeutic indications.
Visit Jaguar on LinkedIn:
https://www.linkedin.com/company/jaguar-health/
Visit Jaguar on Instagram: https://www.instagram.com/jaguarhealthcommunity/
Visit Jaguar on X: https://twitter.com/Jaguar_Health
Phone: 415-371-8300
Contact: hello@jaguar.health
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |